非酒精性脂肪性肝病患者的健康相关生活质量与肝脏炎症相关
基于欧洲非酒精性脂肪性肝病(NAFLD)登记处304例经组织学定义、前瞻性入组的NAFLD患者,分析健康相关生活质量(HRQL)。平均CLDQ总分为5.0±1.2,疲劳维度得分最低;女性得分显著低于男性;肥胖、2型糖尿病、血脂异常与CLDQ得分负相关;小叶炎症和脂肪变程度越重,CLDQ得分越低;多变量分析中性别、年龄、2型糖尿病和炎症与低HRQL独立相关。
要点
- NAFLD患者平均CLDQ总分为5.0±1.2,疲劳维度得分最低(4.3±1.6)。
- 女性CLDQ得分显著低于男性(4.6±1.3 vs 5.3±1.1,P<.001)。
- 小叶炎症0级 vs 3级平均CLDQ得分分别为5.3±1.2 vs 3.9±1.8(P<.001)。
核心结论
- 在欧洲NAFLD登记处数据分析中,患者存在显著的症状负担;除年龄、性别和糖尿病外,肝活检检出小叶炎症与较低HRQL相关。
研究设计与样本
- 研究为欧洲NAFLD登记处的前瞻性入组分析,纳入德国、英国和西班牙304例经组织学定义的NAFLD患者,平均年龄52.3±12.9岁,肝活检采集后6个月内完成慢性肝病问卷(CLDQ)。
主要发现
- 平均CLDQ总分为5.0±1.2,疲劳维度得分最低(4.3±1.6),活动维度得分最高(5.4±1.4)。
- 女性CLDQ得分显著低于男性(4.6±1.3 vs 5.3±1.1,P<.001)。
- CLDQ得分与肥胖(P<.001)、2型糖尿病(P<.001)、血脂异常(P<.01)呈负相关。
- 脂肪变组织学评分1级 vs 3级平均CLDQ得分分别为5.3±1.1 vs 4.5±1.4(P<.01);小叶炎症0级 vs 3级平均CLDQ得分分别为5.3±1.2 vs 3.9±1.8(P<.001)。
- 晚期纤维化(F3-4) vs 早期或中期纤维化(F0-2)对平均CLDQ得分无显著影响(4.9±1.2 vs 5.1±1.3,P=.072)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Chronic liver disease has negative effects on health-related quality of life (HRQL). We analyzed data from the European non-alcoholic fatty liver disease (NAFLD) registry to assess the effects of NAFLD on HRQL. METHODS: We collected data from 304 patients (mean age, 52.3 ± 12.9 years) with histologically defined NAFLD enrolled prospectively into the European NAFLD Registry in Germany, the United Kingdom, and Spain. The chronic liver disease questionnaire (CLDQ) was completed within 6 months of liver biopsy collection. RESULTS: The mean CLDQ overall score was 5.0 ± 1.2, with the lowest score in the category fatigue (4.3 ± 1.6) and the highest scores for activity (5.4 ± 1.4). Women had significantly lower CLDQ scores than men (4.6 ± 1.3 vs 5.3 ± 1.1; P < .001). We found negative correlations between CLDQ scores and presence of obesity (P < .001), type 2 diabetes (P < .001), and dyslipidaemia (P < .01). There was a negative correlation between level of aspartate aminotransferase, but not alanine aminotransferase, and HRQL. Higher histological score of steatosis (1 vs 3) resulted in lower mean CLDQ score (5.3 ± 1.1 vs 4.5 ± 1.4; P < .01); higher level of lobular inflammation (0 vs 3) also resulted in lower mean CLDQ score (5.3 ± 1.2 vs 3.9 ± 1.8; P <. 001). In contrast, advanced fibrosis (F3-4) compared to early or intermediate fibrosis (F0-2) had no significant effect on mean CLDQ score (4.9 ± 1.2 vs 5.1 ± 1.3; P = .072). In multivariate analysis, patients sex, age, presence of type 2 diabetes, and inflammation were independently associated with low HRQL. CONCLUSION: In an analysis of data from the European NAFLD registry, we observed a substantial burden of symptoms in patients. In addition to age, sex, and the presence of diabetes, detection of lobular inflammation in biopsies correlated with lower HRQL.
引用
- Huber Y, Boyle M, Hallsworth K, et al. Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation. Clin Gastroenterol Hepatol. 2018. PMID: 30580090. doi:10.1016/j.cgh.2018.12.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。